15-Minute Summary of APCCC 2026 Highlights on Prostate Cancer

Created using ChatSlide

Explore key insights and expert consensus from the APCCC 2026, focusing on high-risk non-metastatic hormone-sensitive prostate cancer (nmHSPC). This session, organized by the EAU and APCCC, will cover pivotal clinical scenarios, including rising PSA post radical prostatectomy, oligometastatic conditions, and therapy options for nmHSPC. Learn about survivorship considerations with a focus on gynecomastia prophylaxis, based on recommendations from Dr. Aurelius Omlin and Dr. Rashid K. Sayyid,...